510(k) Report

510(k) · Cleared

Cleared

Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)

K260578510(k) TraditionalCleared Jul 14, 2026144-day reviewClass II21 CFR 882.1320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ambu A/S · GXY Electrode, Cutaneous

Cleared on Jul 14, 2026 as substantially equivalent to K242346 (Natus Manufacturing Limited, 2024) after a 144-day review. Its family tree reaches back 5 generations to 1995.

Decided
Jul 14, 2026
Review
144 days
Class
Class II
Product code
GXY
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K942921 (1995). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK942921 Neurolink Eeg/EP/Emg Surface ElectrodesNeuro Supplies, Inc. · 1995
  2. 4 generations backK061148 Rhythmlink Disc ElectrodesRhythmlink International, LLC · 2006
  3. 3 generations backK130287 MR Conditional Cup Electrode, MR Conditional Webb ElectrodeRhythmlink International, LLC · 2013
  4. 2 generations backK172503 MR Conditional Cup Electrode, MR Conditional Webb ElectrodeRhythmlink International, LLC · 2017
  5. 1 generation backK242346 Grass® MR Conditional/CT Cup ElectrodesNatus Manufacturing Limited · 2024
  6. This deviceK260578 Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US…Ambu A/S · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K942921Neurolink Eeg/EP/Emg Surface ElectrodesNeuro Supplies, Inc.1995—
−4K061148Rhythmlink Disc ElectrodesRhythmlink International, LLC2006—
−3K130287MR Conditional Cup Electrode, MR Conditional Webb ElectrodeRhythmlink International, LLC2013—
−2K172503MR Conditional Cup Electrode, MR Conditional Webb ElectrodeRhythmlink International, LLC2017—
−1K242346Grass® MR Conditional/CT Cup ElectrodesNatus Manufacturing Limited2024—
0 (this device)K260578Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US…Ambu A/S2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
FIG. 1 — Lineage of K260578, 1995–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXY device

  1. #1 K232052 Ceribell Instant EEG Headbandscore 16.3 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K242346Grass® MR Conditional/CT Cup Electrodes
Summary page 5
…n: Traditional Predicate Device Trade Name: Grass® MR Conditional/CT Cup Electrodes, Single and Array 510(k) Number: K242346 Manufacturer Name: Natus Manufacturing Limited Reference Device No reference devices were used in…
Natus Manufacturing Limited2024—

Also cleared against K242346: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 4 companies; a new generation was cleared every 6.7 years on median.
  • None of the 6 ancestors has a recall.
  • 1 other device also cites its predicate K242346.

How does its category compare?

All GXY devices

GXY Electrode, Cutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · GXY

6in 2025

2007: 72008: 92009: 172010: 32011: 62012: 92013: 72014: 92015: 62016: 62017: 92018: 142019: 92020: 42021: 122022: 52023: 132024: 72025: 62026 (partial year): 12
2007high 17 (2009) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXY

148in 2025

2007: 88 days median2008: 136 days median2009: 159 days median2010: 137 days median2011: 183 days median2012: 150 days median2013: 99 days median2014: 203 days median2015: 119 days median2016: 170 days median2017: 116 days median2018: 135 days median2019: 113 days median2020: 108 days median2021: 195 days median2022: 81 days median2023: 132 days median2024: 111 days median2025: 148 days median2026 (partial year): 70 days median
2007high 203 (2014) · low 81 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXY

2in 2023

2009: 42010: 12011: 52012: 42023: 2
2007high 5 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXY

58in 2025

2007: 142008: 172009: 152010: 142011: 162012: 162013: 152014: 112015: 192016: 152017: 112018: 102019: 192020: 112021: 212022: 342023: 252024: 512025: 58
2007high 58 (2025) · low 10 (2018)2025

MAUDE reports naming product code GXY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007788014
20089136017
200917159415
20103137114
20116183516
20129150416
2013799015
20149203011
20156119019
20166170015
20179116011
201814135010
20199113019
20204108011
202112195021
2022581034
202313132225
20247111051
20256148058
202612700—

What is it indicated for?

The Ambu® Neuroline™ Cup MRI/CT is intended to obtain and transmit electroencephalography (EEG) or evoked potential (EP) signals to the compatible Ambu harness, from where the signals can be transmitted to a monitoring and recording device.

The Ambu® Neuroline™ Cup MRI/CT is intended to be disconnected from all harness cables and left in place on the patient during Magnetic Resonance (MR) imaging and Computerized Tomography (CT) scanning.

The Ambu® Neuroline™ Cup MRI/CT is indicated when there is a need for neurophysiological examination of the brain.

The Ambu® Neuroline™ Cup MRI/CT can be used for adults and pediatrics (from 2 years and older).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260578: Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260578

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026